Summary
The paper discusses the potential of retinal ganglion cell (RGC) repopulation as a therapeutic approach to reverse vision loss from optic neuropathies, and the challenges and questions that need to be addressed to bring this approach towards clinical translation.
Categories
Eye health: The paper focuses on the potential of retinal ganglion cell (RGC) repopulation to restore vision loss from optic neuropathies, discussing the challenges and questions that need to be addressed to bring this approach towards clinical translation.
Aging: The paper discusses optic neuropathies, which are often age-related, and the potential of RGC repopulation as a therapeutic approach to reverse vision loss from these conditions.
Author(s)
JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley
Publication Year
2023
Number of Citations
4
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance